Table 2.
Parameter | Without AKI (n = 48) | With AKI (n = 8) | P (univariate) | P (multivariate) | OR (95%CI) |
Age (yr) | 41 ± 9 | 55 ± 7 | < 0.001 | ||
Alanine aminotransferase (IU/L) | 156 ± 158 | 62 ± 40 | 0.202 | ||
Albumin (g/L) | 30.1 ± 5.1 | 30.2 ± 2.1 | 0.965 | ||
BUN (mmol/L) | 4.2 ± 2.0 | 5.7 ± 1.1 | 0.065 | ||
Sodium (mEq/L) | 135.3 ± 4.2 | 132.1 ± 3.8 | 0.064 | ||
Total bilirubin (mg/dL) | 19.8 ± 5.6 | 21.3 ± 4.9 | 0.506 | ||
Cr (mg/dL) | 0.9 ± 0.1 | 1.0 ± 0.2 | 0.792 | ||
International normalized ratio | 1.9 ± 0.4 | 2.0 ± 0.3 | 0.367 | ||
MELD score | 24 ± 3 | 26 ± 2 | 0.094 | ||
CysC (mg/L) | 0.9 ± 0.3 | 1.8 ± 0.4 | < 0.001 | 0.021 | 1.8 (1.4–2.3) |
AKI: Acute kidney injury; BUN: Blood urea nitrogen; Cr: Creatinine; CysC: Serum cystatin C; MELD: Model for end-stage liver disease.